Jeffrey Swigris

11PUBLICATIONS
36CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples and disabilityDeep learningMajor global burdens of diseasePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 12, 2024
Interstitial Lung Disease Patients' Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time.

Jeffrey J Swigris, Joseph B Pryor, Kerri I Aronson

|Apr 19, 2024
A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis.

Jeffrey J Swigris, Kerri Aronson, Evans R Fernández Pérez

|Jan 11, 2024
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.

Stephen M Humphries, Devlin Thieke, David Baraghoshi

|Sep 25, 2023
Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease.

Jeffrey J Swigris, Sonye Danoff, Paul F Dellaripa

|Jul 07, 2023
Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?

Kerri Aronson, Susan S Jacobs, Dawn Repola

|Apr 07, 2023
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.

Evans R Fernández Pérez, James L Crooks, David A Lynch

Pageof 2

Frequent Collaborators

2 joint publications

David A Lynch

2 joint publications

Stephen M Humphries

2 joint publications

Joshua J Solomon

1 joint publications

Toby M Maher